If you are not happy with the results below please do another search
Dualsystems Biotech AG Press Release How the LRC-TriCEPS technology works (Video) Zürich Switzerland – June 23, 2014 – Dualsystems Biotech AG offers the most advanced technology for identifying receptor(s) for orphan ligands. The ligand-receptor capture technology (LRC-TriCEPS) is an innovative and conceptually new approach for the unbiased discovery of cell surface interactions of ligands ranging…
Video interview of CaptiRec Services, ligand-receptor capture technology (LRC) with Dr. Paul Helbling, the new management of Dualsystems Biotech AG.
Dualsystems Biotech closes Licensing Agreement with ETH Zurich on Ligand Receptor Capture (LRC) technology Dualsystems Biotech has licensed an innovative technology to discover cell-surface receptors for a vast range of ligands of interest. LRC is centered around an innovative trifunctional chemoproteomic reagent named TriCEPS, which enables the unbiased identification of cell surface receptors for many…
